We describe a case in which a human immunodeficiency virus (HIV)-positive child presented in severe metabolic acidosis secondary to his candidal sepsis and T-cell lymphoma, a rare finding in pediatric AIDS. Significantly elevated levels of Interleukin-10 (IL-10) were found in the patient's serum, which may have played a role in acute demise.
Chuang HC, Lay JD, Hsieh WC, Su IJPathogenesis and mechanism of disease progression from hemophagocytic lymphohistiocytosis to Epstein-Barr virus-associated T-cell lymphoma: Nuclear factor-κB pathway as a potential therapeutic target. Cancer Sci. 2007;98:1281-1287.
2.
Biggar RJ, Engels EA, Frisch, Goedert JJ, for the AIDS Cancer Match Registry Study Group.Risk of T-cell Lymphomas in Persons with AIDS. J Acquir Immune Defic Syndr. 2001;26:371-376.
3.
Funkhouser AW , Katzman PJ, Sickel JZ, Lambert JSCD30-Positive Anaplastic Large Cell Lymphoma of T-cell Lineage in a 14-month old Infant with Perinatally Acquired HIV-1 Infection. Pediatr Hematol Oncol. 1998;20:556-559.
Ruco LP, Di Napoli A., Pilozzi E., et al. Peripheral T cell lymphoma with cytotoxic phenotype: an emerging disease in HIV-infected patients. AIDS Res Hum Retroviruses . 2004;20:129-133.
6.
Collins JA, Hernández AV, Hidalgo JA for the Almenara Hospital AIDS Working Group. , et al. High Proportion of T-Cell Systemic Non-Hodgkin Lymphoma in HIV-Infected Patients in Lima, Peru. J Acquir Immune Defic Syndr.2005;40:558-564.
7.
Anderson P.TIA-1: structural and functional studies on a new class of cytolytic effector molecule. Curr Top Microbiol Immunol. 1995 ;198:131-143.
8.
Antinori A., Cingolani A., Alba L., et al. Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy. AIDS. 2001;15:1483-1491.
9.
Tam HK, Zhang ZF, Jacobson LP, et al. Effect of highly active antiretroviral therapy on survival among HIV-infected men with kaposi sarcoma or non-Hodgkin lymphoma. Int J Cancer. 2002;98:916-922.
10.
Stylianou E. , Aukrust P., Kvale D., Muller F., Froland SSIL-10 in HIV infection: increasing serum IL-10 levels with disease progression-down regulatory effect of potent anti-retroviral therapy. Clin Exp Immunol. 1999;116:115-120.
11.
Breen EC, Boscardin WJ, Detels R., et al. Non-Hodgkin's B cell lymphoma in persons with acquired immunodeficiency syndrome is associated with increased serum levels of IL10, or the IL10 promoter-592C/C genotype. Clin Immunol. 2003;109:119-129.
12.
Mazur B., Mertas A., Sonta-Jakimczyk D., Szczepanski T., Janik-Moszant A.Concentration of IL-2, Il-6, Il-8, Il-10 and TNF-alpha in children with acute lymphoblastic leukemia after cessation of chemotherapy. Hematol Oncol. 2004;22:27-34.
13.
Lehmann AK, Halstensen A., Sørnes S., Røkke O., Waage A.High levels of interleukin 10 in serum are associated with fatality in meningococcal disease. Infect Immun. 1995;63:2109-2112.
14.
van der Graaf CAA , Netea MGm , van der Meer JWM , Kulberg BJDifferential cytokine production and toll-like receptor signaling pathways by Candida albicans Blastoconidia and hyphae. Infect Immunity. 2005;73: 7458-7464.
15.
Taveras D., Ferreira P., Arala-Chaves M.Increased resistance to systemic candidiasis in athymic or interleukin-10-depleted mice. J Infect Dis. 2000;182:266-273.
16.
Mocellin S. , Panelli MC, Wang E., Nagorsen D., Marincola FMThe dual role of IL-10. Trends Immunol. 2003;24:36-43.
17.
Vieira P., de Waal-Malefyt R., Dang MN, et al. Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: Homology to Epstein-Barr virus open reading frame BCRFI . Proc Natl Acad Sci U S A. 1991;88:1172-1176.
18.
Rochford R. , Cannon MJ, Sabbe RE, et al. Common and idiosyncratic patterns of cytokine gene expression by Epstein-Barr virus transformed human B cell lines. Viral Immunol. 1997;10:183-195.
